title: [Hypoxic pulmonary hypertension: modern views on pathogenesis and options for rational pharmacological correction].
abstract: In the article, an analysis of the modern approaches to pharmacological correction of hypoxic pulmonary hypertension in conjunction with its development mechanisms has been performed. Promising research trends for the creation of new drugs in this field have also been reviewed.
authors.forename: Ie V
authors.initials: IeV
authors.lastname: Strielkov
authors.forename: S B
authors.initials: SB
authors.lastname: Frantsuzova
authors.forename: O S
authors.initials: OS
authors.lastname: Khromov
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D015220:Calcium Channels / Q000378:metabolism; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D000860:Hypoxia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D008081:Liposomes / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000187:drug effects / Q000503:physiopathology*; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D018497:Ventricular Dysfunction, Right / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D008081:Liposomes; D010713:Phosphatidylcholines; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D014700:Verapamil